Acquired Hemophilia A and urothelial carcinoma. (Record no. 10819)

MARC details
000 -LEADER
fixed length control field 03029nam a22004097a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210218s20212021 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2000-9666
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/20009666.2020.1836726 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 1836726 [pii]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC7850392 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 33552425
245 ## - TITLE STATEMENT
Title Acquired Hemophilia A and urothelial carcinoma.
251 ## - Source
Source Journal of Community Hospital Internal Medicine Perspectives. 11(1):89-93, 2021 Jan 26.
252 ## - Abbreviated Source
Abbreviated source J Community Hosp Intern Med Perspect. 11(1):89-93, 2021 Jan 26.
253 ## - Journal Name
Journal name Journal of community hospital internal medicine perspectives
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2021
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2021
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
266 ## - Date added to catalog
Date added to catalog 2021-02-18
520 ## - SUMMARY, ETC.
Abstract Acquired Hemophilia A (AHA) is a rare entity, resulting from the production of autoantibodies against Factor VIII of the coagulation cascade. These autoantibodies may develop in response to autoimmune conditions, drugs, neoplastic diseases, and pregnancy. Diagnosis involves clinical presentation, mucocutaneous or intramuscular bleeding, and laboratory findings, such as prolonged activated partial thromboplastin time, decreased levels of Factor VIII, and the presence of Factor VIII autoantibodies. The etiology is diverse, with a variety of underlying culprits. Malignancy-associated AHA has been associated with approximately 15% of cases. Urothelial malignancy-mediated AHA is exceedingly rare, with only two previously published reports. The management of AHA includes stabilization and control of bleeding via the use of hemostatic agents, and elimination of the inhibitor with immunosuppressive therapy. Here, we report a case of AHA secondary to urothelial malignancy and review the pathobiology and pathogenesis of Hemophilia A and AHA. Copyright (c) 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Medical Group
656 ## - INDEX TERM--OCCUPATION
Department Internal Medicine
656 ## - INDEX TERM--OCCUPATION
Department MedStar Health Baltimore Residents
657 ## - INDEX TERM--FUNCTION
Medline publication type Case Reports
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Haas, Christopher
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Paz, Robert
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Suleman, Nawar
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Taza, Fadi
790 ## - Authors
All authors Haas C, Paz R, Suleman N, Taza F
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1080/20009666.2020.1836726">https://dx.doi.org/10.1080/20009666.2020.1836726</a>
Public note https://dx.doi.org/10.1080/20009666.2020.1836726
858 ## - ORCID
ORCID text Suleman, Nawar
-- Taza, Fadi
Orcid <a href="https://orcid.org/0000-0001-6537-7472">https://orcid.org/0000-0001-6537-7472</a>
-- <a href="https://orcid.org/0000-0002-6478-8170">https://orcid.org/0000-0002-6478-8170</a>
Name https://orcid.org/0000-0001-6537-7472
-- https://orcid.org/0000-0002-6478-8170
-- https://orcid.org/0000-0001-6537-7472
-- https://orcid.org/0000-0002-6478-8170
858 ## - ORCID
ORCID text Suleman, Nawar
-- Taza, Fadi
Orcid <a href="https://orcid.org/0000-0001-6537-7472">https://orcid.org/0000-0001-6537-7472</a>
-- <a href="https://orcid.org/0000-0002-6478-8170">https://orcid.org/0000-0002-6478-8170</a>
Name https://orcid.org/0000-0001-6537-7472
-- https://orcid.org/0000-0002-6478-8170
-- https://orcid.org/0000-0001-6537-7472
-- https://orcid.org/0000-0002-6478-8170
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 02/18/2021   33552425 33552425 02/18/2021 02/18/2021 Journal Article

Powered by Koha